Ibrutinib-associated sever skin toxicity: A case of multiple inflamed skin lesions and cellulitis in a 68-year-old male patient with relapsed chronic lymphocytic leukemia – Case report and literature review.
Introduction: Ibrutinib is an oral inhibitor of Bruton's tyrosine kinase that is used for a variety of B cell hematological malignancies. Skin and subcutaneous tissue manifestations have been reported and were witnessed in up to 32% of the patients on ibrutinib. The mechanism in which ibrutinib can...
| Publicado en: | Journal of Oncology Pharmacy Practice Vol. 26; no. 2; pp. 487 - 492 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | case study pictorial tables/charts Journal Article |
| Publicado: |
Sage Publications Inc.
Mar2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |